Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.

Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.

Med Sci Monit. 2005 Apr;11(4):PI31-7. Epub 2005 Mar 24.

PMID:
15795705
2.

Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.

Renke M, Tylicki L, Rutkowski P, Wojnarowski K, Lysiak-Szydlowska W, Rutkowski B.

Scand J Urol Nephrol. 2005;39(6):511-7.

PMID:
16303729
3.

Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.

Tylicki L, Rutkowski P, Renke M, Rutkowski B.

Am J Nephrol. 2002 Jul-Aug;22(4):356-62.

PMID:
12169868
4.
5.

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis.

Rutkowski P, Tylicki L, Renke M, Korejwo G, Zdrojewski Z, Rutkowski B.

Am J Kidney Dis. 2004 Feb;43(2):260-8.

PMID:
14750091
6.

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.

Am J Kidney Dis. 2001 Jul;38(1):18-25.

PMID:
11431176
7.
9.

Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.

Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM.

Nephrol Dial Transplant. 2003 Sep;18(9):1806-13.

PMID:
12937228
10.

Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.

Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.

Hypertens Res. 2004 Dec;27(12):963-70.

11.

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.

Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):146-51.

PMID:
15526251
12.

Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.

Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G.

Nephrol Dial Transplant. 2002 Nov;17(11):1890-6.

PMID:
12401843
13.

[Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].

Tesar V, Zima T, Jirsa M Jr, Crkovská J, Stípek S, Vernerová Z, Seráková M.

Cas Lek Cesk. 1999 Oct 20;138(18):560-4. Czech.

PMID:
10596472
14.

Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy.

Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.

Hypertens Res. 2008 Sep;31(9):1711-7. doi: 10.1291/hypres.31.1711.

PMID:
18971549
15.

Antiproteinuric effects of enalapril and losartan: a pilot study.

White CT, Macpherson CF, Hurley RM, Matsell DG.

Pediatr Nephrol. 2003 Oct;18(10):1038-43. Epub 2003 Aug 12.

PMID:
12920631
16.

Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.

Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP.

J Am Soc Nephrol. 2007 Jun;18(6):1889-98. Epub 2007 May 9.

17.

Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.

Seeman T, Pohl M, Misselwitz J, John U.

Kidney Blood Press Res. 2009;32(6):440-4. doi: 10.1159/000266478. Epub 2009 Dec 17.

18.

Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.

Am J Kidney Dis. 2008 Sep;52(3):475-85. doi: 10.1053/j.ajkd.2008.03.008. Epub 2008 May 12.

PMID:
18468748
19.

Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study.

Tylicki L, Renke M, Rutkowski P, Rutkowski B.

J Ren Nutr. 2002 Apr;12(2):122-5.

PMID:
11953926
20.

Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.

Usta M, Ersoy A, Dilek K, Ozdemir B, Yavuz M, Güllülü M, Yurtkuran M.

J Intern Med. 2003 Mar;253(3):329-34.

Supplemental Content

Support Center